about
Cyanobacterial lipopolysaccharides and human health - a reviewLipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activityA synthetic analog of the 3-deoxy-D-manno-2-octulosonic acid disaccharide moiety of rough-type endotoxins does not bind to mouse peritoneal macrophages and human monocytesLegionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophagesGenetics of O-antigen biosynthesis in Pseudomonas aeruginosa.Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal.Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognitionToll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS.Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent mannerWhat are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in miceBacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide.Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages.Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.Destructive periodontitis lesions are determined by the nature of the lymphocytic response.Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide.SAOS-2 osteosarcoma cells bind fibroblasts via ICAM-1 and this is increased by tumour necrosis factor-α.Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burstCD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.Lipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin.Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides speciesCapsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages.Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.Inhibition of lipopolysaccharide-induced transcription factor Sp1 binding by spectrally pure diphosphoryl lipid A from Rhodobacter sphaeroides, protein kinase inhibitor H-8, and dexamethasone.Protection of mice from endotoxic death by 2-methylthio-ATPPseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins.The in vivo effect of lipopolysaccharide on the spontaneous release of transmitter from motor nerve terminalsTranscriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung diseaseLipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathwaysMolecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses.Platelet activating factor synthesis and metabolism in intestinal ischaemia-reperfusion injury.LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.The tumor necrosis factor-inducing potency of lipopolysaccharide and uronic acid polymers is increased when they are covalently linked to particles.Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist.
P2860
Q21245821-3CFDCB8E-EA32-48DA-A23D-330A428C1920Q24290990-43A40127-588F-4046-A05A-BB2D052250B1Q28386730-3B66DFC0-AE93-46ED-8313-47B893696E3DQ33607039-38A95588-526B-4B1F-8786-66B4699962E5Q33616396-6290967E-BF90-4682-9DEF-DE1BB7189D6AQ33728775-83BC09AC-E8C6-4668-99E7-C03335805C6DQ33752508-6B42715D-5B5D-4564-BFF4-D492E336C2A1Q33754384-9AD88DA1-161C-46E3-B8FC-8B82C484306FQ33897705-6A7D3570-8EF6-47F9-976B-1BD9F99850D2Q33938936-0A4988F5-F912-4D0E-8DAF-DD63BDE5D178Q34000853-498DA458-E607-4308-AE01-989961B7E7AFQ34006644-709EFAC6-A0EB-4C65-A534-CFECCBB25D42Q34069439-9E726FCE-F3A4-424E-BE55-3888CBD574D2Q34174943-E84DE636-8A8B-45BB-8E1D-D90DBB5C233EQ34201538-E5784459-B179-4815-B58C-65E55CB03603Q34534147-69303765-0042-4B48-B204-9333EFCD856DQ34547321-14C71920-F7DC-4CF9-8FA9-516309BC21D5Q34720552-F14A1DF2-12C5-4D76-BADC-8D97FCA86AEBQ35058621-C9D177ED-A5A1-4E23-AF8E-512A30DEE749Q35198460-00305003-2192-49C4-BF39-D7CD2CFEFF2BQ35379174-3865373D-8676-4BAF-BF6D-8AE93AF18C07Q35384263-16C4F69E-65A9-40F5-B720-2DE900467136Q35387180-FDF663E8-EBB3-4FE7-948C-04E885502CCBQ35391444-DB1F5689-908C-435D-8B77-4B6B96F9D380Q35401023-608DC7C8-E82A-4CE1-827D-E4455EF90752Q35474308-F9DC1526-2051-4F3A-88C2-4E45E58B5A06Q35494209-C8778563-3338-4C92-BEC3-BA4674F8606BQ35546236-50AF515D-2493-40E1-B7C8-10886C286E5AQ35547554-3065A9ED-634E-4D78-93AA-CD9856DFC6BBQ35550882-FEF65DA0-7243-4BC3-BF2F-3898B59495A3Q35873007-590E65C4-4DAE-4242-B2B5-D7A86B6D3F3DQ35967062-AF0FCAAB-3181-4479-B27D-9D62089BC20AQ36013461-990D8A8D-0859-4015-B063-C2A055E1D7E5Q36365572-A76EBCF3-65B3-44AF-B9E6-3B70D7E76CEAQ36627635-C009AC56-3C6D-4030-B714-A12883C97B0DQ37381799-93DFDBED-BECB-4F18-831A-004DE9C7B1C3Q38313210-0C2A8771-DC41-41DC-803E-507EBAFACFC2Q38551770-2A6AB901-3386-47B6-BC15-2B2840451DF5Q39519164-CD7EDD8B-EADA-457B-BA4F-549072DA8F28Q39559351-6AB69488-7308-4284-8F45-48C36EA0E3FA
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Lipopolysaccharide antagonists.
@ast
Lipopolysaccharide antagonists.
@en
type
label
Lipopolysaccharide antagonists.
@ast
Lipopolysaccharide antagonists.
@en
prefLabel
Lipopolysaccharide antagonists.
@ast
Lipopolysaccharide antagonists.
@en
P1433
P1476
Lipopolysaccharide antagonists.
@en
P2093
P304
P356
10.1016/0167-5699(92)90009-V
P577
1992-07-01T00:00:00Z